Literature DB >> 16517990

Isotretinoin-induced inflammatory bowel disease.

J L M Passier1, N Srivastava, E P van Puijenbroek.   

Abstract

Three case reports on inflammatory bowel disease associated with use of isotretinoin are described. All three patients were male adolescents, in good health when starting isotretinoin (for acne treatment for about six months). Several weeks after discontinuation of isotretinoin the patients developed severe symptoms requiring hospitalisation. The diagnosis of ulcerative colitis was made in two of these patients, while in the third patient Crohn's disease was diagnosed. Although inflammatory bowel disease is described as an adverse drug reaction in the product information of isotretinoin, few cases have been described so far. The link with prior isotretinoin use may not be recognised by the patient or the physician, since the diagnosis of inflammatory bowel disease is often preceded by several years of vague symptoms. On the other hand, spontaneous onset of inflammatory bowel disease (not related to isotretinoin) cannot be excluded. We appeal to the readers for a reaction to this, to shed more light on the likeliness of this alleged association.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517990

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  7 in total

1.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

2.  Isotretinoin and ulcerative colitis: A case report and review of the literature.

Authors:  Ioannis Papaconstantinou; Anastasios Stefanopoulos; Aspasia Papailia; Christos Zeglinas; Ioannis Georgopoulos; Spyridon Michopoulos
Journal:  World J Gastrointest Surg       Date:  2014-07-27

3.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

Authors:  Seth D Crockett; Ajay Gulati; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864

5.  Presumed isotretinoin-induced, concomitant autoimmune thyroid disease and ocular myasthenia gravis: a case report.

Authors:  Huseyin Gursoy; Idil Cakmak; Nilgun Yildirim; Hikmet Basmak
Journal:  Case Rep Dermatol       Date:  2012-09-16

6.  Exacerbation of inflammatory bowel disease with isotretinoin.

Authors:  Rabaab Bharmal; Simon Hc Anderson
Journal:  JRSM Short Rep       Date:  2010-12-01

7.  Effect of 60 and 90 days of isotretinoin treatment on the structure of the small intestine mucosa in young male Wistar rats.

Authors:  Bruna Fontana Thomazini; Mary Anne Heidi Dolder
Journal:  Interdiscip Toxicol       Date:  2017-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.